BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32976349)

  • 21. Minimal Residual Disease-guided Risk Restratification and Therapy Improves the Survival of Childhood Acute Lymphoblastic Leukemia: Experience From a Tertiary Children's Hospital in China.
    Liao C; Xu X; Shen D; Song H; Xu W; Zhao F; Yang S; Shi S; Liang J; Li S; Tang Y
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):e346-e354. PubMed ID: 30640823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
    Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome.
    Gruhn B; Hongeng S; Yi H; Hancock ML; Rubnitz JE; Neale GA; Kitchingman GR
    Leukemia; 1998 May; 12(5):675-81. PubMed ID: 9593264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome.
    Lashkari HP; Faheem M; Sridevi Hanaganahalli B; Bhat KG; Joshi J; Kamath N; Ahlawat S; B P
    Expert Rev Hematol; 2020 Oct; 13(10):1143-1151. PubMed ID: 32870048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and treatment efficacy analysis of 29 children with mixed phenotype acute leukemia].
    Chen X; Liu F; Guo Y; Zhao BB; Zhang RR; Yang WY; Chen XJ; Zhu XF
    Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):807-812. PubMed ID: 32987459
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib.
    August KJ; Guest EM; Lewing K; Hays JA; Gamis AS
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28062. PubMed ID: 31724803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the efficacy of two successive protocols on pediatric acute lymphoblastic leukemia with E2A-PBX1 fusion gene].
    Mei YY; Gao C; Cui L; Zhao XX; Zhao W; Li WJ; Wang KL; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Li ZG
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):467-71. PubMed ID: 24120066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease.
    Issa GC; Kantarjian HM; Yin CC; Qiao W; Ravandi F; Thomas D; Short NJ; Sasaki K; Garcia-Manero G; Kadia TM; Cortes JE; Daver N; Borthakur G; Jain N; Konopleva M; Khouri I; Kebriaei P; Champlin RE; Pierce S; O'Brien SM; Jabbour E
    Cancer; 2017 Feb; 123(3):459-467. PubMed ID: 27696391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent advances on the treatment of acute childhood leukemia].
    Fujimoto T
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1059-65. PubMed ID: 9239157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary].
    Müller J; Kovács G; Jakab Z; Rényi I; Galántai I; Békési A; Kiss C; Nagy K; Kajtár P; Bartyik K; Masát P; Magyarosy E
    Orv Hetil; 2005 Jan; 146(2):75-80. PubMed ID: 15724956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India.
    Trehan A; Bansal D; Varma N; Vora A
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27762058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on the clinical characteristics of 32 patients with mixed phenotype acute leukemia].
    Zhang YM; Wu DP; Sun AN; Qiu HY; Sun YM; He GS; Jin ZM; Tang XW; Miao M; Fu ZZ; Han Y; Chen SN; Zhu MQ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):12-6. PubMed ID: 21429394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
    Basso G; Veltroni M; Valsecchi MG; Dworzak MN; Ratei R; Silvestri D; Benetello A; Buldini B; Maglia O; Masera G; Conter V; Arico M; Biondi A; Gaipa G
    J Clin Oncol; 2009 Nov; 27(31):5168-74. PubMed ID: 19805690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
    Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine.
    Raanani P; Shpilberg O; Gillis S; Avigdor A; Hardan I; Berkowicz M; Sofer O; Lossos I; Chetrit A; Ben-Yehuda D; Ben-Bassat I
    Leuk Res; 1999 Aug; 23(8):695-700. PubMed ID: 10456666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
    Horstmann MA; Hassenpflug WA; zur Stadt U; Escherich G; Janka G; Kabisch H
    Haematologica; 2005 Dec; 90(12):1701-3. PubMed ID: 16330449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
    Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.